BL-M09D1
/ Sichuan Biokin Pharmaceutical, Systimmune
- LARVOL DELTA
Home
Next
Prev
1 to 5
Of
5
Go to page
1
September 24, 2026
A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma and Other Solid Tumors
(clinicaltrials.gov)
- P2 | N=42 | Not yet recruiting | Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
New P2 trial • Oncology • Solid Tumor • Urothelial Cancer
August 18, 2026
A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Gynecological Malignancies and Other Solid Tumors
(clinicaltrials.gov)
- P2 | N=126 | Not yet recruiting | Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
New P2 trial • Endometrial Cancer • Gynecologic Cancers • Oncology • Ovarian Cancer • Solid Tumor
August 23, 2025
A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Other Solid Tumors
(clinicaltrials.gov)
- P1 | N=31 | Recruiting | Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor
July 09, 2025
A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Other Solid Tumors
(clinicaltrials.gov)
- P1 | N=31 | Not yet recruiting | Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
New P1 trial • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor
June 02, 2025
A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors
(clinicaltrials.gov)
- P1 | N=45 | Recruiting | Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Gastrointestinal Cancer • Solid Tumor
1 to 5
Of
5
Go to page
1